Olanzapine Pamoate Hydrate

• CAT Number: R048404
• CAS Number: 221373-18-8
• Molecular Formula: C40H38N4O7S
• Molecular Weight: 718.825
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine;hydrate
• InChI: InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,18H,7-10H2,1-2H3;1H2
• InChIKey: IZXGHRZKSNKYIY-UHFFFAOYSA-N
• SMILES: CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.O

Olanzapine Pamoate Hydrate(CAT: R048404) is a pharmaceutical compound used in the treatment of certain mental health disorders. Its mode of action involves acting as an atypical antipsychotic by antagonizing serotonin and dopamine receptors in the brain. The pamoate form of olanzapine allows for an extended-release effect, providing a longer duration of action. This medication is utilized in the management of schizophrenia and bipolar disorder, alleviating symptoms such as hallucinations, delusions, and mood disturbances.